Betterlife Pharma Inc (BETRF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0711 +0.0046 (+6.92%) 03/13/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0711 unch (unch) 15:09 ET
for Thu, Mar 13th, 2025
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
01-2024 | 01-2023 | 01-2022 | 01-2021 | 01-2020 | |
Operating Expenses | 2,400 | 7,239 | 8,151 | 14,990 | 14,136 |
Operating Income | -2,400 | -7,239 | -8,151 | -14,990 | -14,136 |
Interest Expense | 34 | 9 | 41 | 5 | 36 |
Other Income | 287 | 76 | -1,384 | -12,206 | -611 |
Pre-tax Income | -2,147 | -7,172 | -9,576 | -27,201 | -14,784 |
Income Tax | N/A | N/A | 133 | N/A | N/A |
Net Income Continuous | -2,147 | -7,172 | -9,709 | -27,201 | -14,784 |
Minority Interests | -7 | -273 | N/A | N/A | N/A |
Net Income | $-2,140 | $-6,899 | $-9,709 | $-27,201 | $-14,784 |
EPS Basic Total Ops | -0.02 | -0.08 | -0.13 | -1.00 | -0.98 |
EPS Basic Continuous Ops | -0.02 | -0.08 | -0.13 | -1.01 | -0.98 |
EPS Diluted Total Ops | -0.02 | -0.08 | -0.13 | -1.00 | -0.98 |
EPS Diluted Continuous Ops | -0.02 | -0.08 | -0.13 | -1.01 | -0.98 |
EPS Diluted Before Non-Recurring Items | -0.02 | -0.08 | -0.13 | -1.00 | -1.00 |
EBITDA(a) | $-2,400 | $-7,225 | $-8,136 | $-14,734 | $-13,074 |